Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd. (SHE:301096)

SHE:301096 Revenue

Hangzhou Bio-Sincerity Pharma-Tech had revenue of 128.73M CNY in the quarter ending March 31, 2025, a decrease of -40.32%. This brings the company's revenue in the last twelve months to 714.95M, down -33.32% year-over-year. In the year 2024, Hangzhou Bio-Sincerity Pharma-Tech had annual revenue of 801.92M, down -21.18%.

• Revenue (ttm): 714.95M
• Revenue Growth: -33.32%
• P/S Ratio: 4.88
• Revenue / Employee: 409.24K
• Employees: 1,747
• Market Cap: 3.49B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	801.92M	-215.52M	-21.18%
Dec 31, 2023	1.02B	410.04M	67.51%
Jan 1, 2023	607.41M	233.10M	62.27%
Dec 31, 2021	374.31M	167.06M	80.61%
Dec 31, 2020	207.25M	50.83M	32.50%